Grünenthal Group (Germany)

Thalidomide in the Treatment of the Mucocutaneous Lesions of the Behcet Syndrome

Vedat Hamuryudan · Annals of Internal Medicine · 1998 · 455 citations

Characterization of the mouse cold‐menthol receptor TRPM8 and vanilloid receptor type‐1 VR1 using a fluorometric imaging plate reader (FLIPR) assay

H‐J Behrendt, Tieno Germann, Clemens Gillen et al. · British Journal of Pharmacology · 2004 · 446 citations · Full text

(–)-(1 R,2 R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol Hydrochloride (Tapentadol HCl): a Novel μ-Opioid Receptor Agonist/Norepinephrine Reuptake Inhibitor with Broad-Spectrum Analgesic Properties

Thomas Tzschentke, Thomas Christoph, Babette Kögel et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 389 citations

Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).

Hiroshi Kobayashi, Manfred Schmitt, Lothar Goretzki et al. · Journal of Biological Chemistry · 1991 · 345 citations · Full text

Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade

Hartmut Geitz, Stefan Handt, K. Zwingenberger · Immunopharmacology · 1996 · 290 citations

Cell Surface Molecules, Signal Transduction, Cell Interaction +12